Naltrexone plus benzodiazepine aids abstinence in opioid-dependent patients.

[1]  George Mendelson,et al.  Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) , 2009 .

[2]  L. Amato,et al.  A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence. , 2002, Addiction.

[3]  P. O'Connor,et al.  Clinical practice. Office-based treatment of opioid-dependent patients. , 2002, The New England journal of medicine.

[4]  V. Modesto-Lowe,et al.  Clinical uses of naltrexone: a review of the evidence. , 2002, Experimental and clinical psychopharmacology.

[5]  T. Shippenberg,et al.  Neural Systems Underlying Opiate Addiction , 2002, The Journal of Neuroscience.

[6]  P. Peterson,et al.  Naltrexone potentiates anti-HIV-1 activity of antiretroviral drugs in CD4+ lymphocyte cultures. , 2001, Drug and alcohol dependence.

[7]  E. Korpi,et al.  Morphine withdrawal increases expression of GABAA receptor &epsis; subunit mRNA in locus coeruleus neurons , 2001, Neuroreport.

[8]  G. Woody,et al.  Naltrexone pharmacotherapy for opioid dependent federal probationers. , 1997, Journal of substance abuse treatment.

[9]  G. Woody,et al.  The Effects of Psychosocial Services in Substance Abuse Treatment , 1993, JAMA.

[10]  J. Krieger,et al.  Thorpy MJ The international classification of sleep disorders , 1992, Neurophysiologie Clinique/Clinical Neurophysiology.

[11]  R. Daroff.  The International Classification of Sleep Disorders , 1991, Neurology.

[12]  M. G. Leardi,et al.  New Italian adaption and standardization of the McGill pain questionnaire , 1990, Pain.

[13]  S. Paul,et al.  Receptors for the age of anxiety: pharmacology of the benzodiazepines. , 1980, Science.

[14]  P. Schönhöfer,et al.  The effect of naloxone on cerebellar cGMP content , 1979, Naunyn-Schmiedeberg's Archives of Pharmacology.

[15]  D. Cheney,et al.  Opiate receptor agonists as modulators of gamma-aminobutyric acid turnover in the nucleus caudatus, globus pallidus and substantia nigra of the rat. , 1978, The Journal of pharmacology and experimental therapeutics.

[16]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1976 .

[17]  R. Melzack.  The McGill Pain Questionnaire: Major properties and scoring methods , 1975, PAIN.

[18]  W. Feuerlein,et al.  [Drug addiction and drug abuse]. , 1969, Munchener medizinische Wochenschrift.

[19]  B. Söderpalm,et al.  Naloxone antagonizes GABAA/benzodiazepine receptor function in rat corticohippocampal synaptoneurosomes , 2000, Journal of Neural Transmission.

[20]  L. Berrino,et al.  RELATIONSHIP BETWEEN PURINERGIC AND GLUTAMATERGIC SYSTEMS IN THE OPIATE WITHDRAWAL SYNDROME , 1995 .

[21]  J. Krystal,et al.  Multiple mechanisms of withdrawal from opioid drugs. , 1984, Annual review of neuroscience.

[22]  L L Iversen,et al.  Naloxone as a GABA antagonist: evidence from iontophoretic, receptor binding and convulsant studies. , 1978, European journal of pharmacology.